[
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Unveils Breakthrough Leadless Pacemaker Advances In New Clinical Trials",
    "summary": "Abbott Laboratories (NYSE:ABT) recently announced promising results from its AVEIR Conduction System Pacing study, showcasing its innovative leadless pacemaker technology. Over the last quarter, the company's stock price movement was relatively flat, rising by 1.15%. This modest gain aligns with broader market trends, where major indexes like the Dow had a slight decline and tech stocks saw some losses. Abbott's positive product announcements, alongside stable earnings and continued dividend...",
    "url": "https://finnhub.io/api/news?id=a090ec3838df83452790af02d922017199f673f9734ad2ee7a22b04e760cedc5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745861953,
      "headline": "Abbott Laboratories (NYSE:ABT) Unveils Breakthrough Leadless Pacemaker Advances In New Clinical Trials",
      "id": 134131039,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) recently announced promising results from its AVEIR Conduction System Pacing study, showcasing its innovative leadless pacemaker technology. Over the last quarter, the company's stock price movement was relatively flat, rising by 1.15%. This modest gain aligns with broader market trends, where major indexes like the Dow had a slight decline and tech stocks saw some losses. Abbott's positive product announcements, alongside stable earnings and continued dividend...",
      "url": "https://finnhub.io/api/news?id=a090ec3838df83452790af02d922017199f673f9734ad2ee7a22b04e760cedc5"
    }
  },
  {
    "ts": null,
    "headline": "PBH or ABT: Which Is the Better Value Stock Right Now?",
    "summary": "PBH vs. ABT: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=ab8c6253afe2ea0acfd8a9c94413b47d1d0f298fdfc46f7693ddecbbb76bef5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745854810,
      "headline": "PBH or ABT: Which Is the Better Value Stock Right Now?",
      "id": 134131040,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "PBH vs. ABT: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=ab8c6253afe2ea0acfd8a9c94413b47d1d0f298fdfc46f7693ddecbbb76bef5c"
    }
  },
  {
    "ts": null,
    "headline": "3 Dividend Stocks to Buy and Hold for the Next Decade",
    "summary": "Three Motley Fool contributors believe they've identified fantastic dividend stocks to buy and hold for the next decade.  Here's why they chose Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), and Pfizer (NYSE: PFE).",
    "url": "https://finnhub.io/api/news?id=f01ba2d3ec3d103af1c134fd9efc60336bacfb9b7cb29f03b3d41a2a0535ef96",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745840820,
      "headline": "3 Dividend Stocks to Buy and Hold for the Next Decade",
      "id": 134115093,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Three Motley Fool contributors believe they've identified fantastic dividend stocks to buy and hold for the next decade.  Here's why they chose Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), and Pfizer (NYSE: PFE).",
      "url": "https://finnhub.io/api/news?id=f01ba2d3ec3d103af1c134fd9efc60336bacfb9b7cb29f03b3d41a2a0535ef96"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic",
    "summary": "Abbott Laboratories, Boston Scientific and Medtronic are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=b5d466e06cfdba68006669f136625721e647b0ce97059bb2d5110823ddc6c887",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745839560,
      "headline": "The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic",
      "id": 134115142,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories, Boston Scientific and Medtronic are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=b5d466e06cfdba68006669f136625721e647b0ce97059bb2d5110823ddc6c887"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price",
    "summary": "There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...",
    "url": "https://finnhub.io/api/news?id=2e6680ff0bddff6b041f99fa14d54c7d435e5006ca1b4fefe85b12c95e73fdb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745838024,
      "headline": "Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price",
      "id": 134115143,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...",
      "url": "https://finnhub.io/api/news?id=2e6680ff0bddff6b041f99fa14d54c7d435e5006ca1b4fefe85b12c95e73fdb2"
    }
  }
]